Post by
tamaracktop on Jan 01, 2021 4:05pm
My persepective
I have often written here that analysts targets aren't worth the paper their written on... at least some analysts.
Let me make my case. Last February, Desjardins came out with a report with a 1 year target of $3.75. Last April, Craig Hallum projected a 1 year target of $4, Roth picked $4.50, and Stifel went way out on a limb and gave Xebec a one year target of $4.80. Those targets were the analysts professional opinions at that time of where this stock will be trading 3 months from now. Ha!
More recently, in October , M Partners, in their infinite wisdom, projected that 9 months from now, Xebec will reach the lofty height of $6.
Even TD, while somewhat more realistic, is not immune. In their initial report dated October 1st, TD's 1 year target was $6.50. Xebec hit $6.50 on December 4th, 65 days later. That's 65 Calendar days. Just over 2 months.
It's important to remeber that analysts aren't wizzards or gurus. It's vitally important to remenber that nor am I.
Sometimes I laugh at the guests on BNN. Some of them are actually painful to watch. They clearly don't have the slightest inkling of an idea about what they're talking about. If I had the chance to talk to some of them, I'd remind them that it's often better to confess ignorance than provide it.
It is quite possible, in my opinion, that Xebec could hit TD's target this month. A melt-up is a very real possibility. In fact I have advised some of my friends who are so overweight Xebec that it bothers me to pick prices between $12 and $14 and put in 30 day good through orders to sell a portion of their positions in case there is an imbalance on the buy side and the stock spikes dramatically.